Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation

  1. Leonardo VM de Assis  Is a corresponding author
  2. Lisbeth Harder
  3. José Thalles Lacerda
  4. Rex Parsons
  5. Meike Kaehler
  6. Ingolf Cascorbi
  7. Inga Nagel
  8. Oliver Rawashdeh
  9. Jens Mittag
  10. Henrik Oster  Is a corresponding author
  1. University of Lübeck, Germany
  2. Karolinska Institute, Sweden
  3. University of Sao Paulo, Brazil
  4. Queensland University of Technology, Australia
  5. University Hospital Schleswig-Holstein, Germany
  6. University of Queensland, Australia

Abstract

Diurnal (i.e., 24-hour) physiological rhythms depend on transcriptional programs controlled by a set of circadian clock genes/proteins. Systemic factors like humoral and neuronal signals, oscillations in body temperature, and food intake align physiological circadian rhythms with external time. Thyroid hormones (THs) are major regulators of circadian clock target processes such as energy metabolism, but little is known about how fluctuations in TH levels affect the circadian coordination of tissue physiology. In this study, a high triiodothyronine (T3) state was induced in mice by supplementing T3 in the drinking water, which affected body temperature, and oxygen consumption in a time-of-day dependent manner. 24-hour transcriptome profiling of liver tissue identified 37 robustly and time independently T3 associated transcripts as potential TH state markers in the liver. Such genes participated in xenobiotic transport, lipid and xenobiotic metabolism. We also identified 10 - 15% of the liver transcriptome as rhythmic in control and T3 groups, but only 4% of the liver transcriptome (1,033 genes) were rhythmic across both conditions - amongst these several core clock genes. In-depth rhythm analyses showed that most changes in transcript rhythms were related to mesor (50%), followed by amplitude (10%), and phase (10%). Gene set enrichment analysis revealed TH state dependent reorganization of metabolic processes such as lipid and glucose metabolism. At high T3 levels, we observed weakening or loss of rhythmicity for transcripts associated with glucose and fatty acid metabolism, suggesting increased hepatic energy turnover. In sum, we provide evidence that tonic changes in T3 levels restructure the diurnal liver metabolic transcriptome independent of local molecular circadian clocks.

Data availability

All experimental data was deposited in the Figshare depository (https://doi.org/10.6084/m9.figshare.20376444.v1). Microarray data was deposited in the Gene Expression Omnibus (GEO) database under access code GSE199998 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE199998)

The following data sets were generated

Article and author information

Author details

  1. Leonardo VM de Assis

    Institute of Neurobiology, University of Lübeck, Lübeck, Germany
    For correspondence
    leonardo.deassis@uni-luebeck.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5209-0835
  2. Lisbeth Harder

    Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  3. José Thalles Lacerda

    Department of Physiology, University of Sao Paulo, Sao Paulo, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  4. Rex Parsons

    Faculty of Health, Queensland University of Technology, Kelvin Grove, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Meike Kaehler

    Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Ingolf Cascorbi

    Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Inga Nagel

    Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Oliver Rawashdeh

    Faculty of Medicine, University of Queensland, Brisbane, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Jens Mittag

    Institute for Endocrinology and Diabetes - Molecular Endocrinology, University of Lübeck, Lübeck, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Henrik Oster

    Institute of Neurobiology, University of Lübeck, Lübeck, Germany
    For correspondence
    henrik.oster@uni-luebeck.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1414-7068

Funding

Deutsche Forschungsgemeinschaft (353-10/1; GRK-1957; CRC-296 LocoTact"")

  • Henrik Oster

Deutsche Forschungsgemeinschaft (CRC-296 LocoTact" (TP14).")

  • Jens Mittag

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Matthew A Quinn, Wake Forest School of Medicine, United States

Version history

  1. Received: April 11, 2022
  2. Preprint posted: April 30, 2022 (view preprint)
  3. Accepted: July 25, 2022
  4. Accepted Manuscript published: July 27, 2022 (version 1)
  5. Version of Record published: August 19, 2022 (version 2)
  6. Version of Record updated: September 12, 2022 (version 3)
  7. Version of Record updated: July 31, 2023 (version 4)

Copyright

© 2022, de Assis et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,175
    views
  • 299
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Leonardo VM de Assis
  2. Lisbeth Harder
  3. José Thalles Lacerda
  4. Rex Parsons
  5. Meike Kaehler
  6. Ingolf Cascorbi
  7. Inga Nagel
  8. Oliver Rawashdeh
  9. Jens Mittag
  10. Henrik Oster
(2022)
Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation
eLife 11:e79405.
https://doi.org/10.7554/eLife.79405

Share this article

https://doi.org/10.7554/eLife.79405

Further reading

    1. Computational and Systems Biology
    2. Evolutionary Biology
    Ryan T Bell, Harutyun Sahakyan ... Eugene V Koonin
    Research Article

    A comprehensive census of McrBC systems, among the most common forms of prokaryotic Type IV restriction systems, followed by phylogenetic analysis, reveals their enormous abundance in diverse prokaryotes and a plethora of genomic associations. We focus on a previously uncharacterized branch, which we denote coiled-coil nuclease tandems (CoCoNuTs) for their salient features: the presence of extensive coiled-coil structures and tandem nucleases. The CoCoNuTs alone show extraordinary variety, with three distinct types and multiple subtypes. All CoCoNuTs contain domains predicted to interact with translation system components, such as OB-folds resembling the SmpB protein that binds bacterial transfer-messenger RNA (tmRNA), YTH-like domains that might recognize methylated tmRNA, tRNA, or rRNA, and RNA-binding Hsp70 chaperone homologs, along with RNases, such as HEPN domains, all suggesting that the CoCoNuTs target RNA. Many CoCoNuTs might additionally target DNA, via McrC nuclease homologs. Additional restriction systems, such as Type I RM, BREX, and Druantia Type III, are frequently encoded in the same predicted superoperons. In many of these superoperons, CoCoNuTs are likely regulated by cyclic nucleotides, possibly, RNA fragments with cyclic termini, that bind associated CARF (CRISPR-Associated Rossmann Fold) domains. We hypothesize that the CoCoNuTs, together with the ancillary restriction factors, employ an echeloned defense strategy analogous to that of Type III CRISPR-Cas systems, in which an immune response eliminating virus DNA and/or RNA is launched first, but then, if it fails, an abortive infection response leading to PCD/dormancy via host RNA cleavage takes over.

    1. Computational and Systems Biology
    Skander Kazdaghli, Iordanis Kerenidis ... Philip Teare
    Research Article

    Imputing data is a critical issue for machine learning practitioners, including in the life sciences domain, where missing clinical data is a typical situation and the reliability of the imputation is of great importance. Currently, there is no canonical approach for imputation of clinical data and widely used algorithms introduce variance in the downstream classification. Here we propose novel imputation methods based on determinantal point processes (DPP) that enhance popular techniques such as the multivariate imputation by chained equations and MissForest. Their advantages are twofold: improving the quality of the imputed data demonstrated by increased accuracy of the downstream classification and providing deterministic and reliable imputations that remove the variance from the classification results. We experimentally demonstrate the advantages of our methods by performing extensive imputations on synthetic and real clinical data. We also perform quantum hardware experiments by applying the quantum circuits for DPP sampling since such quantum algorithms provide a computational advantage with respect to classical ones. We demonstrate competitive results with up to 10 qubits for small-scale imputation tasks on a state-of-the-art IBM quantum processor. Our classical and quantum methods improve the effectiveness and robustness of clinical data prediction modeling by providing better and more reliable data imputations. These improvements can add significant value in settings demanding high precision, such as in pharmaceutical drug trials where our approach can provide higher confidence in the predictions made.